IPP Bureau
Asahi Kasei pushes into human trials with new autoimmune drug candidate
By IPP Bureau - April 22, 2026
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
By IPP Bureau - April 22, 2026
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
By IPP Bureau - April 22, 2026
By cutting pain crises & boosting haemoglobin
Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies
By IPP Bureau - April 22, 2026
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
By IPP Bureau - April 22, 2026
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
By IPP Bureau - April 22, 2026
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
By IPP Bureau - April 22, 2026
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Zyax Chem takes 26% stake in Gaymed Labs
By IPP Bureau - April 22, 2026
Targets high-growth eye care expansion push
Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
By IPP Bureau - April 22, 2026
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0
By IPP Bureau - April 22, 2026
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer
By IPP Bureau - April 22, 2026
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
By IPP Bureau - April 22, 2026
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
India–UK life sciences research to advance through new cross-border innovation corridor
By IPP Bureau - April 22, 2026
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks
By IPP Bureau - April 22, 2026
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
